THR1VE!: Randomized controlled trial to reduce diabetes distress in adolescents with type 1 diabetes
- PMID: 40671259
- PMCID: PMC12434431
- DOI: 10.1111/dme.70107
THR1VE!: Randomized controlled trial to reduce diabetes distress in adolescents with type 1 diabetes
Abstract
Aims: To evaluate the effects of a positive psychology intervention to treat diabetes distress (DD) and improve glycaemic outcomes among adolescents with type 1 diabetes.
Methods: Adolescents ages 13-17 with elevated DD and their caregivers from 2 sites (n = 198 dyads) were randomized to receive enhanced usual care (Diabetes Education) or a Diabetes Education + Positive Affect intervention, delivered via automated text messages. Psychosocial and glycaemic data were collected at baseline, 3 months, 6 months and 12 months. The primary outcomes were changes in diabetes distress (DD) and HbA1c over 12 months.
Results: Adolescents demonstrated high levels of engagement in the trial; overall response to text messages was 91%, and retention was 90% over 12 months. Adolescents in both groups reported reductions in DD from baseline to 12 months (effect size d = 0.40), and they were significantly more likely to move from clinically relevant levels into the normal range of DD than to report increased DD (OR = 2.2, p = 0.002). Adolescents' HbA1c was stable over 12 months. We did not observe significant differences in outcomes between groups. Improvement in DD was associated with decreased HbA1c over time (β = 1.89, p = 0.02).
Conclusions: There was no significant intervention effect on DD or HbA1c. Adolescents in both the Diabetes Education and Diabetes Education + Positive Affect arms reported reduced DD over 12 months. Future studies are needed to determine how to employ the least burdensome, engaging intervention for distressed adolescents.
Keywords: adolescents; distress; mHealth intervention; type 1 diabetes.
© 2025 The Author(s). Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Conflict of interest statement
None of the authors have conflicts of interest to report.
Figures
References
-
- Ebekozien O, Mungmode A, Sanchez J, et al. Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016‐2022) from the T1D Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2023;25(11):765‐773. doi: 10.1089/dia.2023.0320 - DOI - PubMed
-
- Hagger V, Hendrieckx C, Cameron F, Pouwer F, Skinner TC, Speight J. Cut points for identifying clinically significant diabetes distress in adolescents with type 1 diabetes using the PAID‐T: results from Diabetes MILES Youth–Australia. Diabetes Care. 2017;40(11):1462‐1468. doi: 10.2337/dc17-0441 - DOI - PubMed
-
- Hagger V, Hendrieckx C, Cameron F, Pouwer F, Skinner TC, Speight J. Diabetes distress is more strongly associated with HbA1c than depressive symptoms in adolescents with type 1 diabetes: results from Diabetes MILES Youth—Australia. Pediatr Diabetes. 2018;19(4):840‐847. doi: 10.1111/pedi.12641 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
